Black Diamond Therapeutics Inc
BDTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$127.21M
Close$
$6.37
203.2% upside
Current Fair Value
203.2% upsideUndervalued by 203.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $127.21 Million |
|---|---|
| Enterprise Value | $111.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.39 |
| Beta | 3.35 |
| Outstanding Shares | 57,233,413 |
Return
| Return on Equity | -41.43% |
|---|---|
| Return on Assets | -32.51% |
| Return on Invested Capital | -38.79% |
Valuation & Multiples
| P/E Ratio | -2.94 |
|---|---|
| PEG | 2.54 |
| Price to Sales | - |
| Price to Book Ratio | 2.1 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.42 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.8203▲ 139.73% |
|---|---|
| Total Calls | 56,200▼ 75.39% |
| Total Puts | 102,300▲ 5.90% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.45%▲ 0.63% |
|---|---|
| Total Invested | $82.02M▼ 10.87% |
| Investors Holding | 107▼ 3.00% |
ESG Score
No data